Tus kws kho mob
QP58-21 Commercial and MHCP Pharmacy Benefit Exclusion for Vocabria
Hnub Tim pib siv tau lub khoos kas: Lub Xya Hli Ntuj Tim 14, 2021
Tshawb Nrhiav
Nthuav pom cov txiaj ntsig tshwm sim 2171 - 2180 ntawm 3685
Tus kws kho mob
QP2R1-21 Update for New to Market Medical Drugs: Aducanumab, Casimersen, Evinacumab, Idecabtagene Vicleucel, and Pegunigalsidase Alfa
Hnub Tim pib siv tau ntawm lub khoos kas: Rau Hlis Ntuj Tim 23, 2021
Tus kws kho mob
Special Transportation Ride Request Form
Tus kws kho mob
Common Carrier Ride Request Form
Tus kws kho mob
Common Carrier Ride Request Form - Care Coordinator
Tus kws kho mob
Hypoactive Sexual Desire Disorder (HSDD) - Commercial
Prior Authorization, Quantity Limit
Hnub Tim pib siv tau ntawm lub khoos kas: Rau Hlis Ntuj Tim 01, 2025
Tus kws kho mob
Hyperhidrosis - Commercial - Effective Date 03/01/2025
Prior Authorization, Quantity Limit
Hnub Tim pib siv tau lub khoos kas: Lub Peb Hlis Ntuj Tim 01, 2025
Tus kws kho mob
Fintepla - Medicaid
Prior Authorization, Quantity Limit
Hnub Tim pib siv tau ntawm lub khoos kas: Rau Hlis Ntuj Tim 01, 2025
Tus kws kho mob
Fintepla (fenfluramine) - Commercial
Prior Authorization, Quantity Limit
Hnub Tim pib siv tau ntawm lub khoos kas: Rau Hlis Ntuj Tim 01, 2025